Movicol Chocolat

Polyethylene glycol 3350, the active ingredient in Movicol Chocolat, is an osmotic laxative presented as an oral solution for oral use. It is indicated for the relief of constipation and for the management of faecal impaction in adults and children when appropriate.

GNH USA supplies Movicol Chocolat as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to strict quality standards and provides regulatory‑compliant distribution across multiple markets.

Movicol Chocolat, an osmotic laxative, is used to treat conditions affecting bowel regularity.

- Constipation: softens stool and promotes regular bowel movements in patients with functional or chronic constipation. - Faecal impaction: facilitates evacuation of hardened stool in cases of acute impaction. - Chronic idiopathic constipation: provides long‑term relief by maintaining stool softness for ongoing management.

Polyethylene glycol 3350 may be associated with a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal bloating: mild distension of the abdomen. - Nausea: feeling of queasiness. - Diarrhoea: loose stools occurring after dose. - Flatulence: increased intestinal gas. - Abdominal cramps: intermittent stomach pain.

Serious or Rare Side Effects: - Severe electrolyte imbalance: abnormal sodium or potassium levels. - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Persistent diarrhoea: prolonged watery stools leading to dehydration.

When prescribing Movicol Chocolat, several safety considerations should be observed.

- Renal impairment: assess kidney function before use. - Electrolyte disorders: monitor serum electrolytes in patients at risk. - Pediatric use: adjust dose carefully and supervise children. - Concomitant laxatives: avoid simultaneous use of other osmotic agents. - Store at ambient temperature: keep below 25 °C, retain original packaging and protect from moisture.

Polyethylene glycol 3350 can interact with other medicines, altering their absorption or electrolyte balance.

Major Interactions (Avoid): - Lithium: increased lithium levels due to altered renal clearance. - Digoxin: risk of electrolyte‑related toxicity.

Moderate Interactions (Monitor Closely): - Diuretics: potential for additive electrolyte loss. - Antacids containing magnesium or aluminum: may affect osmotic activity. - Oral antibiotics: possible reduction in absorption of the antibiotic.